trending Market Intelligence /marketintelligence/en/news-insights/trending/uyGbHKOCDRET_44BADyuWg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sartorius to buy majority stake in Israel's Biological Industries

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Sartorius to buy majority stake in Israel's Biological Industries

Pharmaceutical equipment supplier Sartorius AG agreed to acquire just over 50% of the shares of Israeli cell culture media company Biological Industries Israel Beit Haemek Ltd. from its owners, Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in a cash transaction worth approximately €45 million.

The deal also includes an option to acquire a further 20% of the shares within three years.

The transaction is set to be finalized by mid-December, subject to customary closing conditions.